Keri Maher
Virginia Commonwealth University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Keri Maher as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:48 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07710534 · Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPNVirginia Commonwealth University · recruiting · Relapsed / Refractory AML, High Risk Myelodysplastic Syndrome, High Risk Myeloproliferative Neoplasms · principal investigator
- Ph1NCT07130695 · Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and ConsolidationVirginia Commonwealth University · withdrawn · Acute Myeloid Leukemia · principal investigator
- Ph4NCT06370000 · Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-InequalityVirginia Commonwealth University · recruiting · Acute Myeloid Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Clinical Protocol and Data Management (CPDM)P30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · fiscal years 2026 · $71,312 awarded in 2026Same name and institution; not confirmed by an ID
- Driving Transformation in NCI-sponsored Clinical Trials through Education, Leadership, and Community Partnership: An NCI-R50 Clinical-Scientist AwardR50CA318775 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · fiscal years 2026 · $129,194 awarded in 2026Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name in acute myeloid leukemia, ranked by citations from NIH iCite, fetched 2026-11-12 10:48 UTC. The ranking covers the 200 most relevant of 2 PubMed records, and a shared surname and initials can bring in a namesake. All 2 on PubMed
- A phase I study of MLN4924 and belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome.Cancer Chemother Pharmacol · 202520 citationsRCR 4.9